| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.22371 |
| P8608 | Fatcat ID | release_wiovuirvnfhktk57y5dixzd2sy |
| P698 | PubMed publication ID | 17265490 |
| P5875 | ResearchGate publication ID | 6540019 |
| P50 | author | Gabriel Herrero-Beaumont | Q42186933 |
| Jaime Branco | Q42873509 | ||
| P2093 | author name string | Emilio Martín-Mola | |
| Domingos Araújo | |||
| Armando Porto | |||
| Francisco Javier Blanco | |||
| Manuel Figueroa | |||
| Pere Benito | |||
| José Andrés Román Ivorra | |||
| José Luis Marenco | |||
| Armando Laffon | |||
| Javier Paulino | |||
| María Del Carmen Trabado | |||
| P2860 | cites work | Osteoarthritis: new insights. Part 2: treatment approaches. | Q34080887 |
| P433 | issue | 2 | |
| P921 | main subject | paracetamol | Q57055 |
| glucosamine | Q32907954 | ||
| knee osteoarthritis | Q1777118 | ||
| osteoarthritis | Q62736 | ||
| placebo | Q269829 | ||
| P304 | page(s) | 555-567 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator | |
| P478 | volume | 56 |
| Q36241253 | A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis |
| Q34242933 | A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project |
| Q35770645 | A randomized comparative study of safety and efficacy of immediate release glucosamine HCL and glucosamine HCL sustained release formulation in the treatment of knee osteoarthritis: A proof of concept study |
| Q29394573 | A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort |
| Q38634272 | Acetaminophen for Chronic Pain: A Systematic Review on Efficacy |
| Q46602405 | Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial |
| Q47789675 | Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial |
| Q24186473 | Chondroitin for osteoarthritis |
| Q39539742 | Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Plac |
| Q36475626 | Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib |
| Q46367849 | Combined glucosamine and chondroitin sulfate provides functional and structural benefit in the anterior cruciate ligament transection model. |
| Q42199154 | Commentary: controversies in NICE guidance on osteoarthritis |
| Q21254655 | Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351] |
| Q35634428 | Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits |
| Q36829505 | Conceptual development of a measure to assess pharmacists' knowledge of herbal and dietary supplements |
| Q54443051 | Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. |
| Q34591000 | Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluation |
| Q24630640 | Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties |
| Q35632275 | Crystalline glucosamine sulfate in the treatment of osteoarthritis: evidence of long-term cardiovascular safety from clinical trials |
| Q30235140 | Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment |
| Q37199641 | Drug insight: aggrecanases as therapeutic targets for osteoarthritis. |
| Q55059136 | Effect of Bushenhuoxue formula on interleukin-1 beta and discoidin domain receptor 2 levels in a rat model of osteoarthritis. |
| Q37735091 | Effect of N-acetylglucosamine administration on cartilage metabolism and safety in healthy subjects without symptoms of arthritis: A case report |
| Q89282120 | Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials |
| Q50459670 | Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial. |
| Q64137153 | Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q33622130 | Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis |
| Q88528202 | Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis |
| Q83810796 | Effects of glucosamine sulfate and exercise therapy on serum leptin levels in patients with knee osteoarthritis: preliminary results of randomized controlled clinical trial |
| Q24606203 | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis |
| Q46801560 | Effects of hexosamines and omega-3/omega-6 fatty acids on pH regulation by interleukin 1-treated isolated bovine articular chondrocytes |
| Q34345032 | Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials |
| Q28081360 | Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis |
| Q26998961 | Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials |
| Q33873723 | Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial. |
| Q37258062 | Efficacy of treatment with glucosamine sulfate in patients with knee effusion due to osteoarthritis |
| Q24647966 | Eggshell membrane in the treatment of pain and stiffness from osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled clinical study |
| Q24645101 | Eggshell membrane: a possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies |
| Q24647595 | Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system |
| Q41623738 | Evaluation of the chondroprotective action of N-acetylglucosamine in a rat experimental osteoarthritis model |
| Q98612959 | Expert Opinion on the Extensive Use of Prescription Crystalline Glucosamine Sulfate in the Multimodal Treatment of Osteoarthritis in Ukraine, Kazakhstan, Uzbekistan, and Armenia |
| Q37354339 | Glucosamine and chondroitin for osteoarthritis |
| Q34656760 | Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis |
| Q45916486 | Glucosamine and chondroitin sulfate in the management of osteoarthritis. Commentary. |
| Q37708334 | Glucosamine and chondroitin use in canines for osteoarthritis: A review |
| Q43090795 | Glucosamine binding to proteins in plasma and synovial fluid and blood cell/plasma partitioning in mouse and man in vitro. |
| Q21284705 | Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolism |
| Q22000860 | Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation |
| Q37960179 | Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations |
| Q24244026 | Glucosamine therapy for treating osteoarthritis |
| Q43090797 | In vitro study of the inhibition and induction of human cytochromes P450 by crystalline glucosamine sulfate. |
| Q47816389 | Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). |
| Q92297638 | Indications of the Neurotomy of Genicular Nerves by Radiofrequency for the Treatment of Knee Osteoarthritis: A Literature Review |
| Q21195259 | Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? |
| Q37798321 | Modern Management of Mild-to-Moderate Joint Pain due to Osteoarthritis: A Holistic Approach |
| Q58910462 | Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs |
| Q40504756 | Non-surgical treatment of osteoarthritis-related pain in the elderly |
| Q38047227 | Nutraceuticals in the management of osteoarthritis : a critical review |
| Q38370302 | Osteoarthritis: A Critical Review |
| Q91879728 | Paracetamol versus placebo for knee and hip osteoarthritis |
| Q40190115 | Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). |
| Q80395750 | Prescription of glucosamine for osteoarthritis: does it work and is it safe? |
| Q92717181 | Protective effect of glucosamine and risedronate (alone or in combination) against osteoarthritic changes in rat experimental model of immobilized knee |
| Q26799421 | Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement |
| Q64245321 | Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Disease |
| Q34423402 | Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. |
| Q34264613 | Role of glucosamine in the treatment for osteoarthritis |
| Q46175901 | Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial |
| Q64245298 | Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis |
| Q47151673 | Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q36225456 | Symptom assessment in knee osteoarthritis needs to account for physical activity level. |
| Q35632646 | Synthesis and characterization of a new Peptide prodrug of glucosamine with enhanced gut permeability |
| Q42728527 | The Effects of Morus alba and Acacia catechu on Quality of Life and Overall Function in Adults with Osteoarthritis of the Knee |
| Q41966032 | The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog. |
| Q37667284 | The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial |
| Q37049693 | The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis |
| Q37154872 | The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis |
| Q37825835 | The role of ADAMTSs in arthritis |
| Q47101159 | Therapeutic Effects of Olive and Its Derivatives on Osteoarthritis: From Bench to Bedside |
| Q63352658 | Type 2 diabetes mellitus and osteoarthritis |
| Q35220305 | Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort |
| Q36570336 | Use of glucosamine and chondroitin in relation to mortality |
| Q37868775 | What about supplements for osteoarthritis? A critical and evidenced-based review |
Search more.